Literature DB >> 17109517

Proposal of a new and simple staging system of colorectal liver metastasis.

Ikuo Nagashima1, Tadahiro Takada, Hirokazu Nagawa, Tetsuichiro Muto, Kota Okinaga.   

Abstract

AIM: To create a new, simple and useful staging system for colorectal liver metastasis analogous to the Tumor Node Metastasis classification system of International Union Against Cancer.
METHODS: A retrospective review was undertaken of 81 consecutive patients who underwent partial hepatectomy for colorectal liver metastases (group 1). Clinical and pathological features of both primary and metastatic liver cancers were entered into a multivariate analysis to determine independent variables helpful in accurately predicting long-term prognosis after hepatectomy. Using selected variables, we created a new staging system like TNM classification. The usefulness of the new staging system was examined in a series of 92 patients from another hospital (group 2).
RESULTS: Multivariate analysis showed that 81 patients in group 1 had significant multiple hepatic tumors with the largest tumor being more than 5 cm in diameter, resectable extrahepatic distant metastases, and independent prognostic factors for poor survival after hepatectomy. Using these three variables, we created a new staging system to classify patients with colorectal liver metastases. Finally, our new staging system classified the patients both in group 1 and in group 2.
CONCLUSION: Our new staging system of colorectal liver metastasis is simple and useful for staging patients.

Entities:  

Mesh:

Year:  2006        PMID: 17109517      PMCID: PMC4087339          DOI: 10.3748/wjg.v12.i43.6961

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Indicators for treatment strategies of colorectal liver metastases.

Authors:  H Ueno; H Mochizuki; K Hatsuse; K Hase; T Yamamoto
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

Authors:  M Minagawa; M Makuuchi; G Torzilli; T Takayama; S Kawasaki; T Kosuge; J Yamamoto; H Imamura
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer.

Authors:  I Nagashima; T Oka; C Hamada; K Naruse; T Osada; T Muto
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

4.  Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment.

Authors:  T Gruenberger; J L Jourdan; J Zhao; J King; D L Morris
Journal:  Arch Surg       Date:  2000-11

5.  Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy.

Authors:  Y Sugawara; J Yamamoto; S Yamasaki; K Shimada; T Kosuge; M Makuuchi
Journal:  Surgery       Date:  2001-04       Impact factor: 3.982

6.  Mesenteric lymph nodes status influencing survival and recurrence pattern after hepatectomy for colorectal liver metastases.

Authors:  Hidehisa Yamada; Hiroyuki Katoh; Satoshi Kondo; Shunichi Okushiba; Toshiaki Morikawa
Journal:  Hepatogastroenterology       Date:  2002 Sep-Oct

7.  Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection.

Authors:  J G Fortner; J S Silva; R B Golbey; E B Cox; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

8.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

Authors:  K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

9.  A proposed classification system for liver metastasis from colorectal carcinoma.

Authors:  N J Petrelli; D C Bonnheim; L O Herrera; A Mittelman
Journal:  Dis Colon Rectum       Date:  1984-04       Impact factor: 4.585

10.  Proposal for a clinical classification of liver metastases.

Authors:  L Gennari; R Doci; F Bozzetti; U Veronesi
Journal:  Tumori       Date:  1982-10-31
View more
  7 in total

1.  Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.

Authors:  Christophe Laurent; Jean-Philippe Adam; Quentin Denost; Denis Smith; Jean Saric; Laurence Chiche
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

2.  The role of peri-operative treatment in resectable liver metastases of colorectal cancer.

Authors:  Alexander Stein; Joern Rüssel; Stefan Peinert; Dirk Arnold
Journal:  Ther Adv Med Oncol       Date:  2010-11       Impact factor: 8.168

Review 3.  Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors:  Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

4.  Staging colorectal cancer with the TNM 7(th): the presumption of innocence when applying the M category.

Authors:  Giacomo Puppa; Graeme Poston; Per Jess; Guy F Nash; Kenneth Coenegrachts; Axel Stang
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

5.  Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Authors:  Ninos Ayez; Zarina S Lalmahomed; Alexander M M Eggermont; Jan N M Ijzermans; Jeroen de Jonge; Kees van Montfort; Cornelis Verhoef
Journal:  Ann Surg Oncol       Date:  2011-10-18       Impact factor: 5.344

Review 6.  Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.

Authors:  Alexander Stein; Gabriel Glockzin; Andreas Wienke; Dirk Arnold; Thomas Edelmann; Bert Hildebrandt; Stephan Hollerbach; Gerald Illerhaus; Alfred Königsrainer; Michael Richter; Hans J Schlitt; Hans-Joachim Schmoll
Journal:  BMC Cancer       Date:  2012-08-16       Impact factor: 4.430

7.  Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status.

Authors:  D J Watkins; I Chau; D Cunningham; S S Mudan; N Karanjia; G Brown; S Ashley; A R Norman; A Gillbanks
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.